Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1287562

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1287562

Cholera Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

PUBLISHED:
PAGES: 143 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

The global cholera vaccines market size reached US$ 4.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.2 Million by 2028, exhibiting a growth rate (CAGR) of 11.1% during 2023-2028.

Cholera is an intestinal disease caused by bacterial infections that spread through contaminated food and water. It leads to severe diarrhea, dehydration, abdominal pain, fever, rapid heart rate, loss of skin elasticity, low blood pressure, muscle cramps, and dry mucous membranes, such as the inside of the mouth, throat, nose, and eyelids. It is presently a global threat to public health, which can be prevented through the vaccine. The cholera vaccine exposes a small dose of live cholera bacteria in the body that helps develop immunity against the disease. It can be given orally or injected intradermally or intramuscularly in the body.

Cholera Vaccines Market Trends:

The growing prevalence of cholera on account of poor hygiene and sanitation represents one of the major factors driving the market. In addition, there is a rise in the use of contaminated water for agriculture and olericulture across the globe. This, along with the increasing consumption of street and fast food due to the hectic lifestyles of individuals, is propelling the growth of the market. Moreover, there is a considerable rise in water pollution on account of sewage and factory wastes getting discharged into lakes and rivers. As a result, people are consuming contaminated seafood worldwide, which, in turn, is resulting in the spread of cholera. Additionally, rising awareness about cholera through initiatives of non-governmental organizations (NGOs), along with numerous immunization programs introduced by governments of several countries to reduce vaccine-preventable diseases, is positively influencing the market. Furthermore, key market players are extensively investing in research and development (R&D) activities to provide more efficient and cost-effective cholera vaccines, which is projected to propel the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cholera vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, product and end user.

Breakup by Vaccine Type:

Whole Cell V. Cholerae O1 with Recombinant B-Subunit

Killed Oral O1 and O139

Breakup by Product:

Dukoral

Shanchol

Vaxchora

Euvichol and Euvichol-Plus

Others

Breakup by End User:

Hospitals and Clinics

Research and Academic Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics Co. Ltd., Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., PharmaChoice Canada Inc, Sanofi S.A., Takeda Pharmaceutical Company Limited and Valneva SE.

Key Questions Answered in This Report:

  • How has the global cholera vaccines market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cholera vaccines market?
  • What are the key regional markets?
  • What is the breakup of the market based on the vaccine type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cholera vaccines market and who are the key players?
  • What is the degree of competition in the industry?
Product Code: SR1623A320_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cholera Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Vaccine Type

  • 6.1 Whole Cell V. Cholerae O1 with Recombinant B-Subunit
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Killed Oral O1 and O139
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Dukoral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Shanchol
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Vaxchora
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Euvichol and Euvichol-Plus
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research and Academic Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Astellas Pharma Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Emergent BioSolutions Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Eubiologics Co. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Johnson & Johnson
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck & Co. Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Pfizer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 PharmaChoice Canada Inc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Valneva SE
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
Product Code: SR1623A320_Report

List of Figures

  • Figure 1: Global: Cholera Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Cholera Vaccines Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Cholera Vaccines Market: Breakup by Vaccine Type (in %), 2022
  • Figure 5: Global: Cholera Vaccines Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Cholera Vaccines Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Cholera Vaccines Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Cholera Vaccines (Whole Cell V. Cholerae O1 with Recombinant B-Subunit) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Cholera Vaccines (Killed Oral O1 and O139) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Cholera Vaccines (Killed Oral O1 and O139) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Cholera Vaccines (Dukoral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Cholera Vaccines (Dukoral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Cholera Vaccines (Shanchol) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Cholera Vaccines (Shanchol) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Cholera Vaccines (Vaxchora) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Cholera Vaccines (Vaxchora) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Cholera Vaccines (Euvichol and Euvichol-Plus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Cholera Vaccines (Other Product) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Cholera Vaccines (Other Product) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Cholera Vaccines (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Cholera Vaccines (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Cholera Vaccines (Research and Academic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Cholera Vaccines (Research and Academic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Cholera Vaccines (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Cholera Vaccines (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Cholera Vaccines Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Cholera Vaccines Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Cholera Vaccines Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Cholera Vaccines Industry: SWOT Analysis
  • Figure 78: Global: Cholera Vaccines Industry: Value Chain Analysis
  • Figure 79: Global: Cholera Vaccines Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cholera Vaccines Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Cholera Vaccines Market Forecast: Breakup by Vaccine Type (in Million US$), 2023-2028
  • Table 3: Global: Cholera Vaccines Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Cholera Vaccines Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Cholera Vaccines Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Cholera Vaccines Market: Competitive Structure
  • Table 7: Global: Cholera Vaccines Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!